Belvedere Trading LLC Q4 2022 Filing

Filed February 15, 2023

Portfolio Value

$37.0B

Holdings

505

Report Date

Q4 2022

Filing Type

13F-HR

All Holdings (505 positions)

#StockSharesValue% PortfolioType
501
1T7TRICIDA INC
20,400$3K0.00%Put
502
—ADAMIS PHARMACEUTICALS CORP
17,841$2K0.00%Call
503
RDHLGBPREDHILL BIOPHARMA LTD
19,000$2K0.00%Put
504
CORZCORE SCIENTIFIC INC
15,982$00.00%Put
505
VTGNUSDVISTAGEN THERAPEUTICS INC
10,161$00.00%Put
PreviousPage 6 of 6